
Tulavi Therapeutics Awarded Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc.
<a href="https://news.google.com/rss/articles/CBMigAJBVV95cUxQUmdDNVVrRDBDVFRBdnE5dUU2WUVsN1FIeXZsd2tYY0ZrWVdpdXl2bTVsc1NCWXJGLUhrbEs0N0o0RkczaGNmTUxKY0FfYXFjSUY3dkZGYWFtaVRxeWxseGlacHV6ZTFhT0hsOG9BR2dWZW9uOWxYMHJzS0tuLXFZVVh4NHczUmpnMVlRekJ4RHlNR1FyeEtVVGl1cXg2MklNeENhdXhwV2UyZDJyMFNfZXAyVmN1MVB3ejYwb051MmZRYkE0c1A1cG83eTVpTE1mcFhsUFhmVzNzcFdjaUw1V0xlUmFOVzkxc050ZTZrT1QtMjkzbThMZ3JjRVlIclM3?oc=5" target="_blank">Tulavi Therapeutics Awarded Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc.</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>
